The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian


September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

Global surface guided radiation therapy (SGRT) devices market is projected to see an extraordinary growth in the forecast period, 2022-2026. The market growth can be attributed to the increasing instances of skin cancer. The advancing novel technology in radiotherapy for the cancer treatment is further substantiating the growth of the market. Moreover, increased adoption of radiotherapy devices and procedures along with the rising preference for the non-surgical procedures are further substantiating the growth of the global SGRT devices market in the upcoming five years.

In addition, the technological advancement in SGRT devices has advantages like patient positioning with real-time feedback, patient monitoring throughout the treatment fraction and motion management. More technical advancements including accelerated partial breast irradiation, particle radiotherapy, and pediatrics are also actively responsible for the growth of the global SGRT devices market in the next five years. However, the high cost of the therapy and the medical device may put a mild restraint on the global SGRT devices market growth in the future five years of forecast until 2026.

Surface guided radiation therapy devices are the medical radiation devices that are utilized for the SGRT. The technology positions and monitors the patient's surface radiation process on the external surface such that the patient's positioning is apt. This procedure provides transitional and rotational information of the patient's skin surface and offers the potential to improve the accuracy of setup. The global devices market segmentation is based on device type, application, end user, regional distribution, and competitional landscape. Based on device type, the market is divided between portable and fixed devices.

Fixed devices are anticipated to hold the largest revenue shares of the market and dominate the market segment on the account of increasing advancement in the healthcare industry dedicated toward oncological treatment and diagnostic processes. Portable devices are expected to register the fastest growing CAGR in the upcoming five years with its added advantage of mobility. These devices are more affordable, and can be installed in smaller healthcare centers, and clinics too, thereby supporting the growth of the global surface guided radiation therapy devices market in the next five years. Added advantages include emission of electrons, photons, and other fast-moving subatomic particles, and use of x-ray tubes to build contact between the device and the targeted area in patient's body.

Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through SGRT devices. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers and acquisitions and new product developments.

For more information: www.researchandmarkets.com/r/t666r5


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Radiation Therapy

May 16, 2024 — Today marks a significant milestone in cancer care with the introduction of bipartisan federal ...

Time May 16, 2024
arrow
News | FDA

May 14, 2024 — Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA ...

Time May 14, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Radiation Dose Management | By Christine Book

Advances in the growing radiation dose management market are continually helping those who administer treatment to focus ...

Time May 03, 2024
arrow
Subscribe Now